Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Busting the Top 3 Myths about Pet Insurance

As pet owners embark on their journey, one crucial question often arises: Should I invest in pet insurance? In an online survey conducted among pet owners in Ireland in November 2023, Agria delves into various topics, including the decisions surrounding insurance coverage for their beloved companions.   Agria Petinsure offers valuable insights on pet insurance, debunking myths and addressing affordability concerns based on recent survey findings. This can help pet owners to make informed decisions for their pets' well-being. "Pet health insurance is expensive.” 31% dog owners

Notice to the Annual General Meeting of Terveystalo Plc

Terveystalo Plc, Notice to the Annual General Meeting, 22 February 2024 at 11:30 EETNotice is given to the shareholders of Terveystalo Plc (the “Company”) to participate in the Annual General Meeting to be held on Tuesday, 26 March 2024 at 3:00 p.m. (EET) in Scandic Marina Congress Center at the address Katajanokanlaituri 6, 00160 Helsinki, Finland. The reception of participants and the distribution of voting tickets will commence at the meeting venue at 2:00 p.m. (EET). Shareholders and their proxy representatives may also exercise their voting rights by voting in advance.

Limited liability companies and co-operatives that have not filed financial statements risk being struck off the Trade Register

The Finnish Patent and Registration Office (PRH), which maintains the Finnish Trade Register, will deregister or place into receivership limited liability companies and co-operatives that have not filed their financial statements for registration. The first deregistration in 2024 now includes ca. 2.500 limited liability companies and co-operatives.The companies in the deregistration must file their financial statements with the Trade Register by  3 June 2024. See the list of the companies in the deregistration (a reminder recorded on 19.2.2024): · Go to the prh.fi website about

Invitation to the presentation and Q&A of the year-end report

On February 29 at 10:00 CET, Speqta will present the year-end report for 2023 for shareholders, media and other stakeholders. Participants will be able to follow the presentation via webcast. CEO Gustav Westman will present the report, which will be followed by a Q&A session with Redeye’s analyst Fredrik Nilsson.. Questions can be submitted ahead of the webcast on the link below, but there will also be opportunities to ask questions live during the webcast. The year-end report will be released on February 29 at 07:00 CET. Time: Thursday February 29, 10:00–11:00 CET. Link

Genexis Group presents the 2023 financial report

Genexis Group’s consolidated Net Sales for Q4 amounted to EUR 15.3 million (Q4 2022; EUR 23.7 million) and the consolidated Adjusted EBITDA of Q4 was EUR 0.7 million (EUR 1.9 million).Net sales Q4 2023 reflects the lower market activity throughout the year, being 36% below the same period last year.Even though Q4 came in low in revenue, the expected increase in activity in the market was visible with a historically high level on order intake totalling EUR 23 million for the quarter. “While certain customers still have high inventories contributing to lower demand for products, an

Ellevio AB publishes Year-end Report 2023

Key financials January–December 2023 · Net sales amounted to SEK 8,231 million (7,535). · Distributed electricity amounted to a total of 24.2 TWh (25.0). · Operating profit amounted to SEK 2,694 million (2,085). · Free cash flow totalled SEK 1,383 million (1,549). · Capital expenditure, including asset acquisitions, amounted to SEK 3,663 million (3,345).The Year-end Report comments on important aspects of Ellevio AB’s operations during the period, including the recent development of the regulatory framework. The report is available on Ellevio’s website: www.ellevio.se/en/

Invitation to presentation of SBB’s year-end report 2023

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) will publish its year-end report for 2023 on 27 February 2024 at 08:00 CET. SBB’s CEO Leiv Synnes will present the results on the same day at 10:00 CET via conference call and webcast. The presentation will be held in English and will be concluded with a Q&A session. Questions can be asked on the conference call or in written form through the webcast. The report will be available at: https://corporate.sbbnorden.se/en/reports-and-presentations/ If you wish to participate via webcast, please use the link below. Via the webcast you

Outokumpu – Announcement regarding change in holdings

Outokumpu OyjStock exchange releaseFebruary 22, 2024 at 11.00 am EETOutokumpu – Announcement regarding change in holdings Outokumpu Oyj (business identity code: 0215254-2) has on February 21, 2024 received a notification based on Chapter 9, Section 5 of the Finnish Securities Market Act. Société Générale SA’s total holding in the shares and voting rights of Outokumpu has risen above 5% and was 5.23% on February 20, 2024. Their earlier holding in the Outokumpu shares and voting rights was below minimum threshold.  Total direct andindirect holdingsof SociétéGénérale SA

Valmet has published the Annual Report, the Corporate Governance Statement and the Remuneration Report for 2023

Valmet has published the Annual Report, the Corporate Governance Statement and the Remuneration Report for 2023   Valmet Oyj’s stock exchange release on February 22, 2024 at 11:00 a.m. EET   Valmet has today, on February 22, 2024, published its Annual Report for 2023 on the company's website at www.valmet.com/annualreport2023. The Annual Report consists of three separate parts: the Annual Review, the Financial Statements and Report of the Board of Directors and the GRI Supplement.   The Annual Review covers Valmet’s operations, strategy, market environment and

Real Advokatbyrå acted as legal advisor for Barings Real Estate in their venture with Innovation Properties regarding the construction of 264 residential units in the greater Stockholm area

Real Advokatbyrå acted as legal advisor for Barings Real Estate in their venture with Innovation Properties regarding the construction of 264 residential units in the greater Stockholm area. The building will have a high sustainability profile with solar panels, wooden structures and will in general be constructed in a green and sustainable way in order to obtain environmental certificates. The constructor is Lindbäcks Bygg. We thank the Barings team for entrusting us and for the great collaboration along the whole process.

Vultus: Toyama's Retailer Network Goes Live on Vultus's New Platform

Vultus AB (publ) announces that Toyama do Brasil Máquinas Ltda's ("Toyama") extensive retail network, encompassing 7,000 stores in Brazil and South America, is going live on Vultus's new platform. Through its retailer network, Toyama will distribute Vultus's analytics service and platform to the agriculture industry. Revenues will initially amount to approximately 1,5 MSEK in fixed fees and will increase with the variable cost per analyzed hectare.Toyama's network will feature a bespoke platform and app, tailored to deliver Vultus's analytics services. These include Nitrogen Prescriptions,

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 42 – 22 FEBRUARY 2024 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Finland Calls for Greater International Collaboration in 6G Research and Development

Recognizing the pivotal role that next-generation connectivity will play in driving economic growth through digitalization and sustainability, Finland is calling for public and private actors around the globe to join forces with its research coalition in the realm of 6G development. Finland has been at the forefront of wireless mobile technology for decades, ever since Nokia launched its first mobile phone in 1982. Building on this expertise and the power of interdisciplinary collaboration, Finland has recently laid the foundations for significant 6G development and positioned

Medivir presents data that strengthens the fostrox/Lenvima combination in primary liver cancer at EASL Liver Cancer Summit

Stockholm — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that clinical pharmacokinetic (PK) data on dose linearity and systemic exposure from the first study with fostroxacitabine bralpamide (fostrox) (NCT03781934) will be presented at the European Association for the Study of the Liver (EASL) Liver Cancer Summit on February 23, 2024, in Rotterdam.   The abstract, titled “Population pharmacokinetic modeling of orally administered fostroxacitabine bralpamide (

Arctic Bioscience – Invitation to presentation of Q4 2023 operational update

Arctic Bioscience will publish a Q4 2023 operational update and preliminary full year 2023 financial results on Friday 1[st] of March, at 08:00 CET.The same day at 11:00 CET, the Company will host a webcast to present the results and give an operational update. Following the presentation, it will be opened for questions from the audience. Webcast details: Date: Friday 1[st] of March 2024 Time: 11:00 CET Format: Webcast and Q&A Language: English The presentation can be accessed through the Company’s website, or with the link below: Link: https://channel.royalcast.com/

Terveystalo's Annual Report 2023 published

Terveystalo Plc Annual Financial Report 22 February 2024 at 10:15 am EET Terveystalo Plc has today published its Annual Report for the year 2023. The Annual Report 2023 consists of four parts: · Year 2023 presents information on Terveystalo’s business operations, market environment, strategy and value creation. · Sustainability describes Terveystalo’s sustainability efforts and their results. The Sustainability -section for 2023 is prepared with reference to the GRI Standards. · Corporate Governance includes the Corporate Governance Statement, Remuneration Policy and

Project update Vestmanna: Dragon 12 functionality verified and power production performance satisfactory and as projected

After the first two weeks of testing, the Dragon 12 functionality is verified and power production performance is satisfactory and as projected. All core operating functions such as starting, turning with the tidal flow and electricity generation have been successfully verified in its first phase of operation. Given the stable system behaviour, Minesto concludes the technology risks of scale-up have been significantly reduced.The Minesto 1.2 MW tidal powerplant - Dragon 12 - has since installation two weeks ago delivered as expected during its first phase of operation at its grid-connected

Year-end report

The .Group October – December 2023 (KSEK) · Net sales 9 590 (4 534) +112% · Operating result -4 169 (-15 606) · Result for the period before tax -5 624 (-14 990) · Earnings per share before and after dilution -0.34* (-1.22) The Group January – December 2023 (KSEK) · Net sales 28 270 (13 260) +113% · Operating result -31 471 (-57 706) · Result for the period before tax -32 224 (-55 942) · Earnings per share before and after dilution -2.50* (-4.56) * Earnings per share after tax, calculated on the result for the period and number of shares,12 624 171Summary

Veidekke: Shares purchased by employees in 2024 and Exercise of employee share options by Key employees

With reference to the stock exchange notice dated February 19, 2024, primary insider notifications pursuant to the market abuse regulation article 19 are attached. For further information, please contact: Jørgen Wiese Porsmyr, CFO, +47 907 59 058, jorgen-wiese.porsmyr@veidekke.no This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Frode van der Laak wins “Best Researcher Award” from the International Congress for Research Excellence

Oslo - Norway, 22nd February 2024:  In an extraordinary recognition of his pioneering research and innovations, Reltime is proud to announce that our Chief Technology Officer, Frode van der Laak, has been awarded the "Best Researcher of the Year" award from International Congress for Research Excellence (ICRE). This prestigious accolade is in honour of his ground-breaking paper, "Utilize 5G Mobile Handset as DAO and Node in Layer 1 Proof of Authority Blockchain." International Congress for Research Excellence 2024 (ICRE 24) is the renowned International Research Award given to

Q2 Interim Report October - December 2023

About Hamlet BioPharma   Hamlet BioPharma is an innovative biotechnology company that develops scientific discoveries into drugs for the treatment of cancer and infections. The goal is to help address unmet medical needs in large patient groups, in need of improved cancer treatments or alternatives to antibiotics. The company is leveraging highly innovative scientific discoveries and an extensive IP portfolio, to take these innovative drugs through mechanistic and preclinical phases, through the development of drug production technology to the clinic. Three projects in clinical

Saab receives support order for Norway’s Combat Training Centre

Saab has received an order from the Norwegian Defence Materiel Organisation regarding support, service and maintenance for the Combat Training Centre in Rena. The order value is approximately SEK 190 million and the contract period is 2024-2027.The contract also includes on-site support for four additional training and simulation locations in Norway, as well as at Rena.  “We are pleased to continue our long-term support to the Norwegian Armed Forces’ training systems. With this contract, we ensure that the Norwegian Armed Forces have the required interoperable training capabilities today

There are no items matching the current filter
There are no more items matching the current filter
Back to top